Outcomes and risk stratification after endovascular therapy for patients with PAD

Outcomes and risk stratification after endovascular therapy for patients with PAD - OPEN-PAD trial

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011329

Enrollment

700

Registered

2013-08-01

Start date

2013-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PAD

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: PAD patient recommended endo vascular therapy. over 20 years old. not exclusion criteria patient. patient with consent of EVT.

Exclusion criteria

Exclusion criteria: patient unavailable of anti platelet agents and anticoagulant. Allergy of contrast agents. Life expectancy 12 months. During pregnancy and suckling. inappropriate patient determined from study director.

Design outcomes

Primary

Measure	Time frame
all cause death non fatal myocardiac infarction stroke	—

Countries

Japan

Contacts

Public ContactMasashi Nakao

Tokyo Women's medical university cardiology

nakaomasashi@gmail.com03-3353-8111

Outcome results